Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NeuPath HealthTSXV:NPTH 39 Days Payable is 49.22 as of Jun. 2026, which is 3% below its 10-year median of 50.97. GuruFocus rates TSXV:NPTH with a GF Score™ of 39/100 and a GF Value™ of C$0.25 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 613 Healthcare Providers & Services companies, NeuPath Health ranks worse than 53.34% on this metric.
The historical rank and industry rank for NeuPath Health's Days Payable or its related term are showing as below:
TSXV:NPTH'
s Days Payable Range Over the Past 10 Years
Min: 47.47 Med: 50.97 Max: 60.15
Current: 52.38
During the past 7 years, NeuPath Health's highest Days Payable was 60.15. The lowest was 47.47. And the median was 50.97.
TSXV:NPTH's Days Payable is ranked worse than 53.34% of 613
companies
in the Healthcare Providers & Services industry
Industry Median: 57.48
vs TSXV:NPTH: 52.38
NeuPath Health's Days Payable
increased
from Jun. 2025 (46.41) to Jun. 2026 (49.22).
It may suggest that NeuPath Healthdelayed paying its suppliers.
The historical data trend for NeuPath Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:NPTH vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, NeuPath Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeuPath Health Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NeuPath Health's Days Payable distribution charts can be found below:
* The bar in red indicates where NeuPath Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
NeuPath Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeuPath Health (TSXV:NPTH) has a Days Payable of 49.22 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NeuPath Health and its competitors. This is near median its historical median of 50.97. Over the past decade, NeuPath Health's Days Payable has ranged from 47.47 to 60.15. According to the industry distribution chart, NeuPath Health ranks #327 out of 613 companies in the Healthcare Providers & Services industry, placing it in the top 53.3%.
Is NeuPath Health's Days Payable too high?
NeuPath Health's current Days Payable of 49.22 is near median its 10-year median of 50.97. Over the past 10 years, this metric has ranged from a low of 47.47 to a high of 60.15. The Healthcare Providers & Services industry median Days Payable is 57.48. NeuPath Health's value of 49.22 is 14.4% below this industry median. Based on the distribution chart, NeuPath Health ranks #327 out of 613 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, NeuPath Health has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NeuPath Health's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, NeuPath Health ranks #327 out of 613 companies for Days Payable. This places NeuPath Health in the lower half of its industry. The industry median Days Payable is 57.48. NeuPath Health's value of 49.22 is 14.4% below this benchmark. Historically, NeuPath Health's own Days Payable has ranged from 47.47 to 60.15 over the past decade. While the company's 10-year median is 50.97 vs. the industry median of 57.48, NeuPath Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.48, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeuPath Health's current Days Payable of 49.22 is 14.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NeuPath Health and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeuPath Health's current Days Payable is 49.22, which is near median its own 10-year median of 50.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuPath Health stock overvalued right now?
Based on GuruFocus' analysis, NeuPath Health (TSXV:NPTH) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.25, compared to a current price of C$0.55 — trading 120% above its estimated fair value. The current Days Payable is 49.22, which is near median its 10-year median of 50.97 and 14.4% below the Healthcare Providers & Services industry median of 57.48. NeuPath Health's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For NeuPath Health (TSXV:NPTH), the current Days Payable is 49.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NeuPath Health (TSXV:NPTH) Overvalued in 2026?
Based on GuruFocus' analysis, NeuPath Health stock appears to be overvalued.
The current stock price of C$0.55 is trading 120% above its estimated GF Value™ of C$0.25.
GuruFocus considers NeuPath Health to be Significantly Overvalued.
Key valuation signals for TSXV:NPTH:
Days Payable: 49.22 (near median its 10-year median of 50.97)
GF Value™: C$0.25 vs. price of C$0.55 (120% above fair value)
Industry Position: 14.4% below the Healthcare Providers & Services median (#327 of 613)
No single metric tells the full story. See the TSXV:NPTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal or back injuries, sports-related injuries, and concussions. The company operates in one industry segment: medical services.
39GF Score
Get the complete analysis for TSXV:NPTH
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:NPTH has been successfully added to your 
